Eyebright Medical Technology (Beijing) Co., Ltd.
SHH: 688050.SS0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Shanghai Stock Exchange
- Sector
- Healthcare
- Industry
- Medical - Instruments & Supplies
- CEO
- Jiangbing Xie
- Employees
- 2,074
- Headquarters
- Beijing, China
- IPO year
- 2020
- Market cap
- CN¥9.8B
- Website
- https://www.ebmedical.com
Loading 688050…
Loading profile data…Frequently asked questions about 688050
What does Eyebright Medical Technology (Beijing) Co., Ltd. (688050.SS) do?
Eye Bright Medical Technology Co., Ltd. develops a range of ophthalmic medical products. Its products include surgical implants and instruments, equipment, optometric lenses, eye drops, etc. for the treatment of ophthalmic diseases and vision problems, such as cataract, glaucoma, refractive errors, and other ophthalmic diseases. The company was...
Where does 688050.SS trade?
Eyebright Medical Technology (Beijing) Co., Ltd. (688050.SS) trades on the Shanghai Stock Exchange.
What sector is 688050.SS in?
Eyebright Medical Technology (Beijing) Co., Ltd. (688050.SS) operates in the Healthcare sector, specifically in the Medical - Instruments & Supplies industry.
Who is the CEO of Eyebright Medical Technology (Beijing) Co., Ltd.?
Jiangbing Xie is the chief executive officer of Eyebright Medical Technology (Beijing) Co., Ltd. (688050.SS).
Where is Eyebright Medical Technology (Beijing) Co., Ltd. headquartered?
Eyebright Medical Technology (Beijing) Co., Ltd. is headquartered in China.
Does 688050.SS pay a dividend?
Yes — Eyebright Medical Technology (Beijing) Co., Ltd. (688050.SS) paid a trailing twelve-month dividend of CNY 0.35 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did 688050.SS go public?
Eyebright Medical Technology (Beijing) Co., Ltd. (688050.SS) completed its initial public offering in 2020.